ALB three-lens brief
Evidence-based stock research on ALB. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -3.02% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved -3.02% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- P/E of 470 — priced for high growth; little margin of safety.
- Analyst mean target $172.56 — 41% above current (20 analysts).
- 8-K filing filed 2026-09-03.
ALB closed at $122.11 (-3.02%) as of 2026-09-11. Market cap: $14.41B. P/E (trailing) 469.7. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $172.56 — 41% above current (20 analysts).. Concerns: moved -3.02% yesterday.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $1.74B, net income $438.27M, free cash flow $1.33B.
Why three lenses on ALB, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ALBacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ALB" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ALB brief"></iframe>